Company Filing History:
1 out of 224 
1 out of 491 
Years Active: 2011
Title: The Innovative Contributions of Peter Brouckaert
Introduction
Peter Brouckaert is a notable inventor based in Ghent, Belgium. He has made significant contributions to the field of cancer treatment through his innovative research and patents. His work focuses on enhancing the effectiveness of cancer therapies, which has the potential to improve patient outcomes.
Latest Patents
One of Peter Brouckaert's key patents is titled "Method of treating cancer by combination therapy using TNF and alpha-galactosylceramide." This invention relates to the treatment of cancer, specifically demonstrating that the anti-cancer activity in mammals can be augmented by administering a combination of a synergistically effective amount of TNF and alpha-galactosylceramide. This innovative approach offers new avenues for cancer therapy.
Career Highlights
Throughout his career, Peter Brouckaert has worked with various organizations, including Vib Vzw and Universiteit Gent. His experience in these institutions has allowed him to collaborate with other experts in the field and contribute to groundbreaking research in cancer treatment.
Collaborations
Peter has collaborated with notable colleagues such as Dirk Elewaut and Leander Huyghe. These partnerships have further enriched his research and have played a crucial role in advancing his innovative work.
Conclusion
Peter Brouckaert's contributions to cancer treatment through his patent and collaborative efforts highlight his dedication to improving healthcare. His innovative methods have the potential to make a significant impact in the fight against cancer.